Viewing Study NCT00333502

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:44 AM
Ignite Modification Date: 2026-05-18 @ 5:48 AM
Study NCT ID: NCT00333502
Status: COMPLETED
Last Update Posted: 2020-05-28
First Post: 2006-06-01
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of CRLX101 (NLG207) in the Treatment of Advanced Solid Tumors
Sponsor: NewLink Genetics Corporation
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
None Solid Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cancer, Neoplasms, Solid Tumor, Ovarian Cancer, Lung Cancer, View
None Non Small Cell Lung Cancer, Pancreatic Cancer, View
None Breast Cancer, Colon Cancer, Endometrial Cancer, View
None Kidney (Renal Cell) Cancer, Melanoma, Prostate Cancer, View
None Skin Cancer, Thyroid Cancer, View
None Solid Malignancies View